Key regions: United Kingdom, Canada, Japan, Europe, China
The demand for dermatological drugs in Northern Africa has been steadily increasing in recent years.
Customer preferences: Customers in Northern Africa are increasingly seeking out dermatological drugs that are effective in treating a wide range of skin conditions, including acne, eczema, psoriasis, and skin infections. They are also looking for products that are affordable and easy to use.
Trends in the market: One of the main trends in the dermatological drugs market in Northern Africa is the increasing availability of generic drugs. This has led to greater competition among manufacturers, which has helped to drive down prices and make these products more affordable for consumers. Another trend is the growing popularity of natural and organic skincare products, which are seen as being gentler on the skin and better for overall health.
Local special circumstances: One of the unique challenges facing the dermatological drugs market in Northern Africa is the prevalence of skin conditions that are specific to the region. For example, the hot and dry climate in many parts of Northern Africa can cause skin to become dry and irritated, leading to conditions like eczema and psoriasis. There is also a higher incidence of skin infections in some areas, due to poor sanitation and hygiene practices.
Underlying macroeconomic factors: The growth of the dermatological drugs market in Northern Africa is being driven by a number of macroeconomic factors, including a growing middle class with increased purchasing power, greater access to healthcare services, and rising awareness of the importance of skincare. In addition, many countries in the region are experiencing economic growth and political stability, which is creating a more favorable business environment for pharmaceutical companies.
Data coverage:
Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.Modeling approach / Market size:
Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
